Last reviewed · How we verify
NCT03717259
Recovery of Short-term Renal Function in Post-transplant Patients Living Donor
NA trial testing Open nephrectomy in Nephrectomy in 508 participants. Completed in 30 December 2017.
1 December 2017
Quick facts
| Lead sponsor | Instituto Mexicano del Seguro Social |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 508 |
| Start date | 1 January 2016 |
| Primary completion | 1 December 2017 |
| Estimated completion | 30 December 2017 |
Drugs / interventions tested
- Open nephrectomy
- Hand-assisted laparoscopic nephrectomy
- Laparoscopic nephrectomy
Conditions studied
- Nephrectomy — all drugs for Nephrectomy →
Sponsor
Instituto Mexicano del Seguro Social — full company profile →
Who can join
Eligibility, any sex, with Nephrectomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Objectives: To describe and analyze the perioperative and functional evolution of short-term renal graft in patients with kidney transplantation from a live donor, comparing three surgical techniques for obtaining kidney graft: open nephrectomy, laparoscopic hand-assisted nephrectomy, and pure laparoscopic nephrectomy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03717259
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Nephrectomy
Currently open trials in the same condition.
- NCT07294859 — Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy · recruiting
- NCT07088874 — Novel Biomarkers and Postoperative Kidney Injury in Radical Nephrectomy · recruiting
- NCT07062952 — Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery · NA · recruiting
- NCT06886087 — Assessment of Risks of Perinephric Fat Thickness to Adverse Renal Outcomes Post Donor Nephrectomy · recruiting
- NCT05149196 — Goal-directed Hemodynamic Management and Kidney Injury After Radical Nephrectomy or Nephroureterectomy · NA · recruiting
Other Instituto Mexicano del Seguro Social trials
Trials by the same sponsor.
- NCT07536009 — "Effectiveness of a Telerehabilitation Program Versus a Conventional Rehabilitation Program in Patients With Subacromial · NA · not yet recruiting
- NCT06632184 — Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic Cholecystectomy · Phase 4 · active not recruiting
- NCT07073846 — Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery. · Phase 4 · recruiting
- NCT07406971 — Safety of Transmucosal Capsaicin Sphenopalatine Ganglion Stimulation in Acute Ischemic Stroke · Phase 2 · recruiting
- NCT07134504 — Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico. · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03717259 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto Mexicano del Seguro Social
- Last refreshed: 24 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03717259.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing